Total amount raised
$65.3 Million
Latest funding date
2024-09-19
Location
GC Therapeutics has developed a "plug-and-play" induced pluripotent stem cell (iPSC) cellular programming platform called TFome™, designed to overcome the complexities of cell therapy development and scaling. The platform leverages synthetic biology, gene editing, cell engineering, and machine learning to deliver iPSC-based medicines more rapidly and efficiently.
Keep reading to explore the intricacies of GC Therapeutics' fundraising journey and the investors backing this innovative platform.
What Is GC Therapeutics?
GC Therapeutics is a biotechnology company specializing in cell therapy and regenerative medicine. The company leverages its TFome™ platform to revolutionize cell therapy by using advancements in synthetic biology, gene editing, cell engineering, and machine learning.
Founded by George Church, Ph.D., and Parastoo Khoshakhlagh, Ph.D., GC Therapeutics focuses on developing therapies for gastrointestinal, neurological, and immunological diseases. The team is composed of visionary scientists and operators dedicated to pushing the boundaries of cell therapy.
How Much Funding Has GC Therapeutics Raised?
- Seed Round
- Amount Raised: USD 339,893
- Date: October 2023
- Series A Round
- Amount Raised: USD 65,000,000
- Date: September 2024
- Lead Investors: Alumni Ventures, Cormorant Asset Management
GC Therapeutics has raised a total of USD 65,339,893 in funding.
Key Investors
- Alumni Ventures
- Details: Alumni Ventures is a venture capital firm that invests in high-growth startups. They leverage a network of alumni from top universities to identify and support promising companies.
- Investment Focus Areas: Technology, healthcare, consumer products
- Notable Investments: SpaceX, Robinhood, DraftKings
- Cormorant Asset Management
- Details: Cormorant Asset Management is a healthcare-focused investment firm. They specialize in investing in innovative biotechnology and life sciences companies.
- Investment Focus Areas: Biotechnology, pharmaceuticals, medical devices
- Notable Investments: Moderna, CRISPR Therapeutics, Intellia Therapeutics
Use Clay to Get Funding Data
Sales professionals, leverage Clay’s platform to access comprehensive fundraising data on companies like GC Therapeutics and gather other critical business insights. Sign up for free to start transforming your sales strategy today.
